• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期卵巢癌患者恶性肠梗阻的非手术治疗:系统评价和荟萃分析。

Non-Surgical Management of Malignant Bowel Obstruction in Advanced Ovarian Cancer patients: A Systematic Review and Meta-Analysis.

机构信息

Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.

出版信息

Am J Hosp Palliat Care. 2022 Jul;39(7):838-846. doi: 10.1177/10499091211043079. Epub 2021 Sep 7.

DOI:10.1177/10499091211043079
PMID:34490792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9210105/
Abstract

BACKGROUND

Malignant bowel obstruction is a common cause of morbidity and mortality in patients with advanced ovarian cancer. Many patients aren't suitable for, or decline, surgical decompression. The outcomes for this frail group of patients are not well characterized.

AIM

To evaluate survival outcomes of ovarian cancer patients who undergo non-surgical management of malignant bowel obstruction.

DESIGN

Systematic review and meta-analysis.

DATA SOURCES

Online literature search of Pubmed, Embase and Medline libraries up until December 2020. Searching abstracts of scientific meetings, reference lists of included studies and contacting experts in the field.

SELECTION CRITERIA

Studies that investigated non-surgical management of confirmed bowel obstruction in advanced ovarian cancer patients were included. All levels of evidence including RCTs, cohort studies and case-series if they included greater than 5 patients.

DATA COLLECTION AND ANALYSIS

The studies were independently chosen by two reviewers who extracted and analyzed the data separately through OpenMeta Analyst software. Study quality was assessed using the JADAD score and the Newcastle Ottawa Score.

RESULTS

24 studies met the eligibility criteria for the systematic review and 9 for the meta-analysis. Median survival of patients managed non-surgically for bowel obstruction was 44 days (95% CI 38-49 days, I  = 0%, P = 0.128).

CONCLUSION

The quality of studies was relatively low, however the evidence shows that non-surgical management of bowel obstruction results in a short life expectancy but with controlled symptoms. Where quality of life is the main concern, this may be a feasible and effective strategy.

摘要

背景

恶性肠梗阻是晚期卵巢癌患者发病率和死亡率的常见原因。许多患者不适合或拒绝手术减压。这组脆弱患者的预后情况尚未得到很好的描述。

目的

评估接受非手术治疗恶性肠梗阻的卵巢癌患者的生存结果。

设计

系统评价和荟萃分析。

数据来源

截至 2020 年 12 月,在 Pubmed、Embase 和 Medline 库中进行在线文献检索。检索科学会议摘要、纳入研究的参考文献列表,并联系该领域的专家。

选择标准

纳入研究调查了晚期卵巢癌患者确诊的肠梗阻的非手术治疗。包括随机对照试验、队列研究和病例系列研究在内的所有证据级别,如果纳入患者超过 5 例。

数据收集和分析

两位评审员独立选择研究,并通过 OpenMeta Analyst 软件分别提取和分析数据。使用 JADAD 评分和纽卡斯尔渥太华量表评估研究质量。

结果

24 项研究符合系统评价的纳入标准,9 项研究符合荟萃分析的纳入标准。非手术治疗肠梗阻的患者中位生存期为 44 天(95%CI 38-49 天,I = 0%,P = 0.128)。

结论

研究的质量相对较低,但证据表明,非手术治疗肠梗阻会导致预期寿命较短,但症状得到控制。如果生活质量是主要关注点,这可能是一种可行且有效的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a1/9210105/5c3eef9d5886/10.1177_10499091211043079-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a1/9210105/73a61768c56e/10.1177_10499091211043079-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a1/9210105/5c3eef9d5886/10.1177_10499091211043079-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a1/9210105/73a61768c56e/10.1177_10499091211043079-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a1/9210105/5c3eef9d5886/10.1177_10499091211043079-fig2.jpg

相似文献

1
Non-Surgical Management of Malignant Bowel Obstruction in Advanced Ovarian Cancer patients: A Systematic Review and Meta-Analysis.晚期卵巢癌患者恶性肠梗阻的非手术治疗:系统评价和荟萃分析。
Am J Hosp Palliat Care. 2022 Jul;39(7):838-846. doi: 10.1177/10499091211043079. Epub 2021 Sep 7.
2
Palliative surgery versus medical management for bowel obstruction in ovarian cancer.卵巢癌肠梗阻的姑息性手术与内科治疗对比
Cochrane Database Syst Rev. 2010 Jul 7;2010(7):CD007792. doi: 10.1002/14651858.CD007792.pub2.
3
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.手术治疗晚期妇科和胃肠道癌症所致恶性肠梗阻以缓解症状。
Cochrane Database Syst Rev. 2000(4):CD002764. doi: 10.1002/14651858.CD002764.
4
Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee.晚期妇科和胃肠道癌症恶性肠梗阻手术的系统评价。系统评价指导委员会。
Gynecol Oncol. 1999 Dec;75(3):313-22. doi: 10.1006/gyno.1999.5594.
5
Bowel obstruction in elderly ovarian cancer patients: a population-based study.老年卵巢癌患者的肠梗阻:基于人群的研究。
Gynecol Oncol. 2013 Apr;129(1):107-12. doi: 10.1016/j.ygyno.2012.12.028. Epub 2012 Dec 26.
6
Possible role of palliative surgery for bowel obstruction in advanced ovarian cancer patients.姑息性手术在晚期卵巢癌患者肠梗阻治疗中的可能作用。
Eur J Gynaecol Oncol. 2010;31(1):31-6.
7
Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC).复发性上皮性卵巢癌(EOC)所致肠梗阻的手术治疗结局。
Gynecol Oncol. 2012 Apr;125(1):31-6. doi: 10.1016/j.ygyno.2011.11.007. Epub 2011 Nov 12.
8
Malignant bowel obstruction in advanced ovarian cancer.晚期卵巢癌所致恶性肠梗阻
Future Oncol. 2017 Mar;13(6):513-521. doi: 10.2217/fon-2016-0431. Epub 2017 Jan 18.
9
Management of primary and metastatic malignant small bowel obstruction, operate or palliate. A systematic review.原发性和转移性恶性小肠梗阻的治疗:手术还是姑息治疗。一项系统评价。
ANZ J Surg. 2021 Mar;91(3):282-290. doi: 10.1111/ans.16188. Epub 2020 Aug 31.
10
Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis.内镜结肠支架置入术作为左半结肠癌和直肠癌性肠梗阻手术治疗桥梁的安全性和疗效:系统评价和荟萃分析。
Surg Oncol. 2013 Mar;22(1):14-21. doi: 10.1016/j.suronc.2012.10.003. Epub 2012 Nov 24.

本文引用的文献

1
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.晚期妇科癌症中的恶性肠梗阻:多学科视角的最新综述
Obstet Gynecol Int. 2018 May 17;2018:1867238. doi: 10.1155/2018/1867238. eCollection 2018.
2
Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.卵巢癌肠梗阻的治疗模式、结局及成本
Int J Gynecol Cancer. 2017 Sep;27(7):1350-1359. doi: 10.1097/IGC.0000000000000998.
3
Using our own developed stent in the palliative treatment of obstruction in the left half of the colon due to ovarian cancer.
使用我们自主研发的支架对卵巢癌所致左半结肠梗阻进行姑息治疗。
Ginekol Pol. 2017;88(1):1-4. doi: 10.5603/GP.2016.0098.
4
Malignant bowel obstruction in advanced ovarian cancer.晚期卵巢癌所致恶性肠梗阻
Future Oncol. 2017 Mar;13(6):513-521. doi: 10.2217/fon-2016-0431. Epub 2017 Jan 18.
5
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.手术治疗晚期妇科和胃肠道癌症恶性肠梗阻的症状缓解。
Cochrane Database Syst Rev. 2016 Jan 4;2016(1):CD002764. doi: 10.1002/14651858.CD002764.pub2.
6
Management of intestinal obstruction in advanced malignancy.晚期恶性肿瘤肠梗阻的管理
Ann Med Surg (Lond). 2015 Aug 1;4(3):264-70. doi: 10.1016/j.amsu.2015.07.018. eCollection 2015 Sep.
7
Venting Gastrostomy at Home for Symptomatic Management of Bowel Obstruction in Advanced/Recurrent Ovarian Malignancy: A Case Series.居家排气胃造口术用于晚期/复发性卵巢恶性肿瘤肠梗阻的症状管理:病例系列
J Palliat Med. 2015 Aug;18(8):722-8. doi: 10.1089/jpm.2014.0355. Epub 2015 Jun 4.
8
Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer.比较奥曲肽和丁溴东莨菪碱对晚期卵巢癌所致无法手术的肠梗阻患者症状控制效果的随机临床试验。
World J Surg Oncol. 2015 Feb 15;13:50. doi: 10.1186/s12957-015-0455-3.
9
Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer.经皮放置上消化道减压管治疗卵巢癌合并恶性肠梗阻的结局。
Gynecol Oncol. 2013 Apr;129(1):103-6. doi: 10.1016/j.ygyno.2013.01.021. Epub 2013 Jan 29.
10
Bowel obstruction in elderly ovarian cancer patients: a population-based study.老年卵巢癌患者的肠梗阻:基于人群的研究。
Gynecol Oncol. 2013 Apr;129(1):107-12. doi: 10.1016/j.ygyno.2012.12.028. Epub 2012 Dec 26.